BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.
Novartis India Ltd: key numbers
- Share price
- ₹1,800.85
- Market cap
- ₹4,446 Cr
- Revenue (annual)
- ₹354.3 Cr
- Net profit (annual)
- ₹93.18 Cr
- P/E (TTM)
- 45.5×Sector 46.1×
- Promoter holding
- 70.68%+0.00% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novartis India Ltd
All →Novartis India Management Change
Evonile Pharma (formerly Novartis India) appointed Mr. Gagan Sharma as President – Specialty Business and Senior Management Personnel effective October 26, 2026. The filing is a Regulation 30 senior management appointment intimation.
Novartis India Other Announcement
Novartis India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This is a routine periodic disclosure.
Novartis India Annual General Meeting
Evonile Pharma (fka Novartis India) issued a postal ballot notice for shareholder votes on ESOP 2026 grant to the MD & CEO and creation of charge on assets. E-voting runs 14 Oct–12 Nov 2026.
Novartis India Fund Raise of ₹900 Cr
Evonile Pharma Limited approved a rights issue to raise up to ₹900 Crore. The company also formed a committee to manage the issuance terms.
- Value
- ₹900.0 Cr
Novartis India Credit Rating
Evonile Pharma Limited has received credit ratings from CARE Ratings Limited for its bank facilities. The company disclosed the ratings as part of its regulatory filings.
Novartis India Other Announcement
Novartis India Limited has changed its corporate name to Evonile Pharma Limited, effective October 01, 2026, following approval from the Ministry of Corporate Affairs.
Other board meeting date announcements
All →Hannah Joseph Hospital Board Meeting Date
Hannah Joseph Hospital Ltd intimated a Board meeting on 05/11/2026 to approve H1 FY27 unaudited results. The trading window has been closed pending that announcement.
Kinetic Trust Board Meeting Date
Kinetic Trust Ltd intimated a Board meeting on 04/11/2026. The agenda includes approval of quarterly financial statements.
Lake Shore Realty Board Meeting Date
Lake Shore Realty Ltd has scheduled a board meeting on 02 Nov 2026 to approve unaudited standalone financial results for Q2 H1 FY27. No other agenda items specified beyond routine matters.
GTV Engineering Board Meeting Date
GTV Engineering scheduled a Board Meeting for 5 November 2026 to approve unaudited Q2 and half-year financial results. No new information is disclosed beyond the meeting notice.
Elixir Capital Board Meeting Date
Elixir Capital Ltd notified BSE that its Board will meet on 6 Nov 2026 to consider Q2/H1FY27 results. No financial figures or decisions are reported yet.
Ecofinity Atomix Board Meeting Date
Ecofinity Atomix Ltd intimated BSE of a Board meeting on 7 November 2026 to consider Q2 and H1 FY27 unaudited results. No financial figures are stated.